2nd Disclosure and Transparency for Clinical Data Summit – 2nd Disclosure and Transparency for Clinical Data Summit
CONFERENCE CHAIR Liz Roberts, Senior Director, Global Lead, Transparency and Data, Sharing, UCB
Sulochana Gawande, Head of Submission Writing and Director of Publications — Oncology Business Group, EISAI
Yolanda Davis, Quality Assurance Manager — Clinical Trial Disclosure, UNIVERSITY OF MIAMI
Oladayo Oyelola, Ph.D., SC (ASCP), Director, Clinical Trial Information Disclosure, DAIICHI SANKYO, INC.
Nathaniel Root, Associate Director, Clinical Disclosure and Transparency, IONIS PHARMACEUTICALS, INC.
To combat the burden of new regulatory requirements, operational challenges and renewed infrastructure needs, the life science industry must take a holistic and collaborative approach to achieving data disclosure compliance. Through data disclosure and transparency, life science organizations decrease the chances of clinical trial duplication, ensure public understanding and access, and ultimately promote brand integrity.
At the 2nd Disclosure and Transparency for Clinical Data Summit, the star-studded speaking faculty will define standardization processes for disclosure and registry, provide best practices to balance commercial confidentiality and public access, and examine proven tactics that preserve data utility while ensuring adequate anonymization. This summit will provide you with the tools to ultimately maximize the benefits of clinical data from the inherent risks of clinical trials, all while complying with national and global compliance regulations.
Top Five Reasons to Attend
Discuss the description of the risk-based approach to balance patient privacy with data utility
Propose best practices for clinical development planning that include effective collaboration leading to practical disclosure solutions
Discuss emerging best practices for tracking and managing global disclosure
Limit internal data discrepancies by merging resources across data integrity, validation and transparency departments
Encourage sprightly adaptation, regardless of company size, to new regulations through novel infrastructure
Who Should Attend
This conference is designed for professionals from pharmaceutical companies with responsibilities in the following areas:
Clinical Trial Disclosure and Transparency
Clinical Trial Information Disclosure/Management
Clinical Trial Registration
Strategic Projects Management
This event is also of interest to:
Data Reporting/Transparency Solution Providers
Medical Writing/Publication Services
Discrepancy Management/Data Management Service Provider